Cipla ready to launch COVID-19 treatment drug favipiravir
Cipla is set to launch coronavirus COVID-19 treatment drug favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process
Cipla Ready To Launch Coronavirus COVID-19 Treatme | 24/07/2020 | By Darshana | 322
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy